Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.1 (
protein kinase
)
81,284
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Deoxynivalenol (DON) is a mycotoxin produced by
Fusarium
spp. that causes
Fusarium
head blight (FHB) disease in cereal crops. Ingestion of food contaminated with DON poses serious human health complications. However, the DON cytotoxicity has been mostly deduced from animal studies. In this study, we used the nematode
Caenorhabditis elegans
(
C. elegans
) as a tractable animal model to dissect the toxic effect of DON. Our results indicate that DON reduces the fecundity and lifespan of
C. elegans
. Real-time quantitative polymerase chain reaction (RT-qPCR) analysis showed that DON upregulates innate immunity-related genes including
C17H12
.8
and
K08D8.5
encoding PMK-1 (mitogen activated
protein kinase
-1)-regulated immune effectors, and
F35E12.5
encoding a CUB-like domain-containing protein. Furthermore, our RNAseq data demonstrate that out of ~17,000
C. elegans
genes, 313 are upregulated and 166 were downregulated by DON treatment. Among the DON-upregulated genes, several are
ugt
genes encoding UDP-glucuronosyl transferase (UGTs) which are known to be involved in chemical detoxification. The three upregulated genes,
F52F10.4
(
oac-32
),
C10H11.6
(
ugt-26
) and
C10H11.4
(
ugt-28
) encoding the O-acyltransferase homolog, UGT26 and UGT 28, respectively, are shown to contribute to DON tolerance by a RNAi bacterial feeding experiment. The results of this study provide insights to the targets of DON cytotoxicity and potential mitigation measures.
...
PMID:Transcriptome Analysis of
C. elegans
Reveals Novel Targets for DON Cytotoxicity. 2995 91